“Periprosthetic joint infection remains one of the most common reasons for failure of hip and knee replacement,” Bryan Springer, MD, an orthopedic surgeon and chair of the AAHKS Education Council. “Because periprosthetic joint infections are associated with such high morbidity and mortality, we felt there was a dire need for perioperative management recommendations that could be subscribed by both disciplines in order to provide arthritis patients with better outcomes.”
Three key recommendations from the guideline are:
- Stopping biologic therapy prior to surgery for patients with inflammatory arthritis
- Stopping tofacitnib for a week before surgery for patients with rheumatoid arthritis, spondyloarthritis and juvenile idiopathic arthritis
- Withholding rituximab and belimumab before surgery for patients with lupus undergoing arthroplasty
View the entire guideline on the ACR website.
More articles in infection prevention:
Hand hygiene rap video takes home APIC Film Festival prize
Removing sinks from ICU rooms reduces bacterial colonization, study finds
Ureteroscope cleaning and sterilization processes leave instruments contaminated, study finds
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.